Denosumab - Amgen
At a glance
- Drug Originator Amgen
- Drug Licenced by AstraZeneca; BeiGene; Clinigen; Daiichi Sankyo Company; Dr Reddys Laboratories; GSK
- Drug Class Antihypercalcaemics; Antineoplastics; Antirheumatics; Calcium regulators; Immunotherapies; Monoclonal antibodies; Osteoporosis therapies
- Mechanism of Action Antibody-dependent cell cytotoxicity; RANK ligand inhibitors
- USA Patent Applicants AMGEN
- USA Patents 170
- BLAs 1
- International Patents 1,329

Disclaimer